Monoacylglycerol Acyltransferase Lipid Yield in Transgenic Plants

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for increasing lipid yields in transgenic organisms, such as plants, algae, and fungi, are limited by the lack of effective pathways for synthesizing non-polar lipids like DAGs and TAGs, which are crucial for biofuel production and industrial applications.

Innovation Solution

The transgenic expression of a monoacylglycerol acyltransferase (MGAT) gene leads to significant increases in lipid yield by introducing a new pathway for DAG and TAG synthesis, distinct from the Kennedy pathway, thereby enhancing the total non-polar lipid content in plants, seeds, leaves, algae, and fungi.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Quantity of substance

If the Kennedy pathway is used for TAG synthesis in plants, then the pathway is well-established and understood, but the lipid yield and non-polar lipid content are limited

Engineering Contradiction:
Improvelipid yieldVSAvoidpathway complexity
Core Design Contradiction:
Quantity of substanceVSDevice complexity

Solution Approach 1:

The invention introduces a segmented alternative pathway by expressing mammalian MGAT and DGAT enzymes separately in plant cells. The MGAT enzyme performs the first segmentation step (converting MAG to DAG), while DGAT performs the second step (converting DAG to TAG). This segmentation allows bypassing the limitations of the native Kennedy pathway while maintaining modularity and control over lipid synthesis.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The invention uses mammalian enzymes (MGAT and DGAT) as intermediary catalysts to transfer the lipid synthesis function from the plant's native Kennedy pathway to an alternative mammalian pathway. These intermediary enzymes act as mediators that enable the conversion of plant-derived substrates (MAG, DAG) into increased TAG production, effectively bridging two different biochemical systems.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Quantity of substance

If transgenic expression of MGAT is used to increase non-polar lipid content, then lipid yield increases substantially, but the metabolic pathway complexity increases

Engineering Contradiction:
Improvenon-polar lipid contentVSAvoidmetabolic pathway complexity
Core Design Contradiction:
Quantity of substanceVSDevice complexity

Solution Approach 1:

The invention merges the functions of multiple enzymes (MGAT and DGAT) into a coordinated two-step pathway within the plant cell. By combining these enzyme expressions, the system achieves substantial increases in non-polar lipid content (up to 25% weight basis) while organizing the complexity into a manageable two-step process that builds upon the existing Kennedy pathway rather than completely replacing it.

Inventive Principle:
Principle #5Merging (Combining)

3Productivity

If the Kennedy pathway is used for TAG synthesis, then the pathway is native to plants, but the pathway does not efficiently produce sufficient non-polar lipids for biofuel applications

Engineering Contradiction:
ImproveTAG production efficiencyVSAvoidpathway flexibility
Core Design Contradiction:
ProductivityVSAdaptability or versatility

Solution Approach 1:

Instead of trying to optimize the native Kennedy pathway from within, the invention inverts the approach by introducing the entire mammalian lipid synthesis pathway (MGAT-DGAT) as an alternative system. This inversion allows the plant to utilize mammalian enzymatic logic for lipid production, achieving higher TAG production efficiency (up to 25% weight basis) while maintaining the flexibility to regulate both pathways independently.

Inventive Principle:
Principle #13The other way round (Inversion)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach results in a substantial increase in non-polar lipid content, potentially up to 25% weight basis, making the transgenic organisms more suitable for biofuel production and industrial applications by optimizing lipid storage and synthesis.

Implementation Method 1

The monoacylglycerol acyltransferase (MGAT) enzyme is associated with mammals, primarily with the intestine in mammals where it catalyzes the synthesis of diacylglycerol (DAG) directly from monoacylglycerol (MAG) and fatty acyl-CoA

Methodology Applied
Scientific EffectEnzyme catalysis: Enzyme

Implementation Method 2

Following synthesis of DAG, another enzyme, diacylglycerol acyltransferase (DGAT), acylates DAG to form TAG

Methodology Applied
Scientific EffectEnzyme catalysis: Enzyme

Implementation Method 3

In the Kennedy pathway, DAG is formed from an acylated glycerol backbone in a two-step reaction consisting of an initial acylation by lysophosphatidic acid acyltransferase (LPAAT) which adds a fatty acyl-CoA to a lysophosphatidic acid (LysoPA; LPA) substrate

Methodology Applied
Scientific EffectEnzyme catalysis: Enzyme

Data Source

PatentUS10925293B2Methods of producing lipids
Publication Date: 2021.02.23 NUSEED GLOBAL INNOVATION LTD
  • US10925293B2 patent drawing
  • US10925293B2 patent drawing
  • US10925293B2 patent drawing

AI summary

The present invention relates to methods of producing lipids. In particular, the present invention relates to methods of increasing the level of one or more non-polar lipids and/or the total non-polar lipid content in a transgenic organism or part thereof. In one particular embodiment, the present invention relates to the use of an acyltransferase, for example, a monoacylglycerol acyltransferase (MGAT) to increase the level of one or more non-polar lipids and/or the total non-polar lipid content in plants, plant seed and/or leaves, algae and fungi.